Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: Implications in multidrug resistance in cancer

International Journal of Cancer

Volumn 109, Issue 2, 2004, Pages 174-181

  Fu, Dong ^a   Bebawy, Mary ^a   Kable, Eleanor P W ^a   Roufogalis, Basil D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Green fluorescent protein; Multidrug resistance in cancer; P glycoprotein; P glycoprotein intracellular localization; Protein trafficking

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC ANTIBIOTIC; BREFELDIN A; DAUNORUBICIN; GLYCOPROTEIN P; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MONENSIN; PHOTOPROTEIN;

ARTICLE; CANCER RESISTANCE; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG RESISTANCE; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; GOLGI COMPLEX; HELA CELL; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; METABOLISM; MULTIDRUG RESISTANCE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIFUNGAL AGENTS; BREFELDIN A; CELL MEMBRANE; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, CONFOCAL; MONENSIN; NEOPLASMS; P-GLYCOPROTEIN; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS;

EID: 1242274510     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11659     Document Type: Article

References (35)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan IA, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39: 361-98.
2. Dean M, Rzhetsky A, Alliknets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 2001;11:1156-66.
3. Shen D, Pastan I, Gottesman MM. Cross-resistance to methotrexate and metals in human cisplatin-resistance cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res 1998; 58:268-75.
4. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nature Reviews Cancer 2002;2: 48-58.
5. Schmitt CA, Lowe SW. Apoptosis and chemoresistance in transgenic cancer models. J Mol Med 2002;80:137-46.
6. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455:152-62.
7. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
8. Gottesman MM, Pastan I. Clinical trials of agents that reverse multidrug resistance. J Clin Oncol 1989;7:409-11.
9. Rothenberg M, Ling V. Multidrug resistance: molecular biology and clinical relevance. J Natl Cancer Inst 1989;81:907-10.
10. Bebawy M, Morris MB, Roufogalis BD. Selective modulation of P-glycoprotein-mediated drug resistance. Br J Cancer 2001;85:1998-2003.
11. Willingham MC, Richert ND, Cornwell MM, Tsuruo T, Hamada H, Gottesman MM, Pastan IH. Immunocytochemical localization of p170 at the plasma membrane of multidrug-resistant human cells. J Histochem Cytochem 1987;35:1451-6.
12. Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000;85:217-29.
13. Duensing TD, Slate DL. Intracellular expression of P-glycoprotein in a human colon tumor cell line. Anticancer Res 1994;14:13-9.
14. Arancia G, Molinari A, Calcabrini A, Meschini S, Cianfriglia M. Intracellular P-glycoprotein in multidrug resistance tumor cells. Ital J Anat Embryol 2001;106:59-68.
15. Kim H, Barroso M, Samanta R, Greenberger L, Sztul E. Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. Am J Physiol 1997;273:C687-702.
16. George AM, Davey MW, Mir AA. Functional expression of the human MDR1 gene in Escherichia coli. Arch Biochem Biophys 1996;333:66-74.
17. Kipp H, Arias IM. Newly synthesized canalicular ABC transporters are directly targeted from the Golgi to the hepatocyte apical domain in rat liver. J Bio Chem 2000;275:15917-25.
18. Faneyte IF, Kristel PM, van de Vijver MJ. Determining MDR1/ P-glycoprotein expression in breast cancer. Int J Cancer 2001;93:114-22.
19. 2+ pump of endo(sarco)plasmic reticulum. J Biol Chem 2000;275:31361-8.
20. 2+ ATPases: a plural, species-specific, and multiple hypertension-regulated expression system. Hypertension 2000;35:91-102.
21. McIntosh AL, Gallegos AM, Atshaves BP, Storey SM, Kannoju D, Schroeder F. Fluorescence and multiphoton imaging resolve unique structural forms of sterol in membranes of living cells. J Biol Chem 2003;278:6384-403.
22. Huxham IM, Barlow AL, Lewis AD, Plumb J, Mairs RJ, Gaze MN, Workman P. Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysis. Int J Cancer 1994;59:94-102.
23. Page RL, Hughes CS, Huyan S, Sagris J, Trogdon M. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines. Anticancer Res 2000;20:3533-8.
24. High S, Lecomte FJ, Russell SJ, Abell BM, Oliver JD. Glycoprotein folding in the endoplasmic reticulum: a tale of three chaperones? FEBS Lett 2000;476:38-41.
25. Chen Y, Simon SM. In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity. J Cell Biol 2000;148:863-70.
26. Chen Y, Pant AC, Simon SM. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells. Cancer Res 2001;61:7763-9.
27. Maraldi NM, Zini N, Santi S, Scotlandi K, Serra M, Baldini N. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Biol Cell 1999;91:17-28.
28. Molinari A, Calcabrini A, Meschini S, Stringaro A, Bufalo DD, Cianfriglia M, Arancia G. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int J Cancer 1998;75:885-93.
29. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992; 355:33-45.
30. Molinari A, Cianfriglia M, Meschini S, Calcabrini A, Arancia G. P-glycoprotein expression in the Golgi apparatus of multidrug-resistance cells. Int J Cancer 1994;59:789-95.
31. Labroille G, Belloc F, Bilhou-Nabera C, Bonnefille S, Bascans E, Boisseau MR, Bernard P, Lacombe F. Cytometric study of intracellular P-gp expression and reversal of drug resistance. Cytometry 1998;32:86-94.
32. Gleeson PA. Targeting of proteins to the Golgi apparatus. Histochem Cell Biol 1998;109:517-32.
33. Klausner RD, Donaldson JG, Lippincott-Schwartz J, Brefeldin A. Insights into the control of membrane traffic and organelle structure. J Cell Biol 1992;116:1071-80.
34. Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK, Zhang M, Blanchette-Mackie J, Santamarina-Fojo S, Brewer Jr HB. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 2001;276:27584-90.
35. Mollenhauer HH, Morre DJ, Rowe LD. Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity. Biochim Biophys Acta 1990;1031:225-46.